Premium
Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: Proceedings from the 6th international post‐ASH symposium
Author(s) -
AbdelWahab Omar,
Pardanani Animesh,
Bernard Olivier A.,
Finazzi Guido,
Crispino John D.,
Gisslinger Heinz,
Kralovics Robert,
Odenike Olatoyosi,
Bhalla Kapil,
Gupta Vikas,
Barosi Giovanni,
Gotlib Jason,
Guglielmelli Paola,
Kiladjian JeanJacques,
Noel Pierre,
Cazzola Mario,
Vannucchi Alessandro M.,
Hoffman Ronald,
Barbui Tiziano,
Thiele Juergen,
Van Etten Richard A.,
Mughal Tariq,
Tefferi Ayalew
Publication year - 2012
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.23169
Subject(s) - medicine , disease
Immediately after the annual scientific meeting of the American Society of Hematology (ASH), a select group of clinical and laboratory investigators in myeloproliferative neoplasms (MPN) is summoned to a post-ASH conference on chronic myeloid leukemia and the BCR-ABL1-negative MPN. The 6th such meeting occurred on December 13–14,2011, in La Jolla, California, USA, under the direction of its founder,Dr. Tariq Mughal. The current document is the first of two reports on this post-ASH event and summarizes the most recent preclinical and clinical advances in polycythemia vera, essential thrombocythemia,and primary myelofibrosis.